These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 25312398

  • 1. Prognostic value of lymph node ratio in patients with advanced epithelial ovarian cancer.
    Ataseven B, Grimm C, Harter P, Prader S, Traut A, Heitz F, du Bois A.
    Gynecol Oncol; 2014 Dec; 135(3):435-40. PubMed ID: 25312398
    [Abstract] [Full Text] [Related]

  • 2. Prognostic value of lymph node ratio in stage IIIC epithelial ovarian cancer with node-positive in a SEER population-based study.
    Zhou J, He ZY, Li FY, Sun JY, Lin HX, Wu SG, Chen QH.
    Oncotarget; 2016 Feb 16; 7(7):7952-9. PubMed ID: 26788911
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Defining the optimal lymphadenectomy cut-off value in epithelial ovarian cancer staging surgery utilizing a mathematical model of validation.
    Pereira A, Irishina N, Pérez-Medina T, Magrina JF, Magtibay PM, Kovaleva A, Rodríguez-Tapia A, Iglesias E.
    Eur J Surg Oncol; 2013 Mar 16; 39(3):290-6. PubMed ID: 23290581
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The prognostic relevance of node metastases in optimally cytoreduced advanced ovarian cancer.
    Bachmann C, Brucker SY, Kraemer B, Rothmund R, Staebler A, Fend F, Wallwiener D, Grischke EM.
    J Cancer Res Clin Oncol; 2015 Aug 16; 141(8):1475-80. PubMed ID: 25739827
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Feasibility, safety and clinical outcomes of cardiophrenic lymph node resection in advanced ovarian cancer.
    Cowan RA, Tseng J, Murthy V, Srivastava R, Long Roche KC, Zivanovic O, Gardner GJ, Chi DS, Park BJ, Sonoda Y.
    Gynecol Oncol; 2017 Nov 16; 147(2):262-266. PubMed ID: 28888540
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Lymph node metastasis in patients with epithelial ovarian cancer macroscopically confined to the ovary: review of a single-institution experience.
    Ulker V, Kuru O, Numanoglu C, Akbayır O, Polat I, Uhri M.
    Arch Gynecol Obstet; 2014 May 16; 289(5):1087-92. PubMed ID: 24213097
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Lymph node ratio and surgical quality are strong prognostic factors of rectal cancer: results from a single referral centre.
    Leonard D, Remue C, Abbes Orabi N, van Maanen A, Danse E, Dragean A, Debetancourt D, Humblet Y, Jouret-Mourin A, Maddalena F, Medina Benites A, Scalliet P, Sempoux C, Van den Eynde M, De Schoutheete JC, Kartheuser A.
    Colorectal Dis; 2016 Jun 16; 18(6):O175-84. PubMed ID: 27128602
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.